HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers

BACKGROUND: HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. METHODS: This was a prospective, cross sectional and observational study conducted on Hydroxychloroquine (HCQ) among Healthcare Workers (HCWs) at Max Super Specialit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Sujeet, Batra, Nitish, Siddiqui, Samreen, Yadav, Ashutosh, Misra, Archa, Loomba, Menka, Sethi, Sumeet, Waghdhare, Swati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654303/
https://www.ncbi.nlm.nih.gov/pubmed/33714413
http://dx.doi.org/10.1016/j.ihj.2020.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654303/
https://www.ncbi.nlm.nih.gov/pubmed/33714413
http://dx.doi.org/10.1016/j.ihj.2020.11.005

Ejemplares similares